Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

GQ-16, a Novel Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Ligand, Promotes Insulin Sensitization without Weight Gain

Full text
Author(s):
Show less -
Amato, Angelica A. [1] ; Rajagopalan, Senapathy [2] ; Lin, Jean Z. [3] ; Carvalho, Bruno M. [4] ; Figueira, Ana C. M. [5] ; Lu, Jenny [2] ; Ayers, Stephen D. [2] ; Mottin, Melina [6] ; Silveira, Rodrigo L. [6] ; Souza, Paulo C. T. [6] ; Mourao, Rosa H. V. [7] ; Saad, Mario J. A. [4] ; Togashi, Marie [1] ; Simeoni, Luiz A. [1] ; Abdalla, Dulcineia S. P. [8] ; Skaf, Munir S. [6] ; Polikparpov, Igor [9, 10] ; Lima, Maria C. A. [11] ; Galdino, Suely L. [11] ; Brennan, Richard G. [12] ; Baxter, John D. [2] ; Pitta, Ivan R. [11] ; Webb, Paul [2] ; Phillips, Kevin J. [2] ; Neves, Francisco A. R. [1]
Total Authors: 25
Affiliation:
Show less -
[1] Univ Brasilia, Lab Farmacol Mol, Dept Ciencias Farmaceut, Fac Ciencias Saude, BR-70919970 Brasilia, DF - Brazil
[2] Methodist Hosp, Res Inst, Diabet Res Ctr, Houston, TX 77030 - USA
[3] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 - USA
[4] Univ Estadual Campinas, Dept Med Interna, BR-13083887 Sao Paulo - Brazil
[5] Brazilian Assoc Synchrotron Light Technol, Natl Inst Biosci, BR-13083970 Sao Paulo - Brazil
[6] Univ Estadual Campinas, Inst Chem, BR-13084862 Sao Paulo - Brazil
[7] Univ Fed Oeste Para, Lab Bioprospeccao & Biol Expt, BR-68040070 Santarem, Para - Brazil
[8] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-05508900 Sao Paulo - Brazil
[9] Univ Sao Paulo, BR-13560970 Sao Carlos, SP - Brazil
[10] Inst Fis Sao Carlos, Dept Fis, BR-13560970 Sao Carlos, SP - Brazil
[11] Univ Fed Pernambuco, Dept Antibiot, BR-50670901 Recife, PE - Brazil
[12] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 - USA
Total Affiliations: 12
Document type: Journal article
Source: Journal of Biological Chemistry; v. 287, n. 33, p. 28169-28179, AUG 10 2012.
Web of Science Citations: 59
Abstract

The recent discovery that peroxisome proliferator-activated receptor gamma (PPAR gamma) targeted anti-diabetic drugs function by inhibiting Cdk5-mediated phosphorylation of the receptor has provided a new viewpoint to evaluate and perhaps develop improved insulin-sensitizing agents. Herein we report the development of a novel thiazolidinedione that retains similar anti-diabetic efficacy as rosiglitazone in mice yet does not elicit weight gain or edema, common side effects associated with full PPAR gamma activation. Further characterization of this compound shows GQ-16 to be an effective inhibitor of Cdk5-mediated phosphorylation of PPAR gamma. The structure of GQ-16 bound to PPAR gamma demonstrates that the compound utilizes a binding mode distinct from other reported PPAR gamma ligands, although it does share some structural features with other partial agonists, such as MRL-24 and PA-082, that have similarly been reported to dissociate insulin sensitization from weight gain. Hydrogen/deuterium exchange studies reveal that GQ-16 strongly stabilizes the beta-sheet region of the receptor, presumably explaining the compound's efficacy in inhibiting Cdk5-mediated phosphorylation of Ser-273. Molecular dynamics simulations suggest that the partial agonist activity of GQ-16 results from the compound's weak ability to stabilize helix 12 in its active conformation. Our results suggest that the emerging model, whereby ``ideal{''} PPAR gamma-based therapeutics stabilize the beta-sheet/Ser-273 region and inhibit Cdk5-mediated phosphorylation while minimally invoking adipogenesis and classical agonism, is indeed a valid framework to develop improved PPAR gamma modulators that retain antidiabetic actions while minimizing untoward effects. (AU)

FAPESP's process: 10/08680-2 - Molecular aspectos of lignocellulosic biomass degradation: dynamics of enzymes and plant cell wall nanoarchitecture
Grantee:Rodrigo Leandro Silveira
Support type: Scholarships in Brazil - Doctorate
FAPESP's process: 10/17048-8 - Regulation of genic transactivation and transrepression mediated by nuclear receptors
Grantee:Ana Carolina Migliorini Figueira
Support type: Regular Research Grants
FAPESP's process: 09/14108-2 - Molecular dynamics simulations of nuclear receptors: ligand-protein free energy estimates
Grantee:Paulo Cesar Telles de Souza
Support type: Scholarships in Brazil - Doctorate